Michael I. Nishimura

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus”.

Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009147

N/A

0.763DataRank · unranked

13 citations

Elizabeth M. Brahmbhatt, Elena Cherkasova, Timothy T. Spear, Ujjawal Savani, Stephanie Pierre +13 more

A class-mismatched TCR bypasses MHC restriction via an unorthodox but fully functional binding geometry

Nature Communications(2022)10.1038/s41467-022-34896-0

N/A

0.449DataRank · unranked

19 citations

Jesus A. Alonso, Jason R. Devlin, Grant L. J. Keller, George I. Gray, Adarsh Kumar Chiranjivi +9 more

Endothelin-1–Mediated Drug Resistance in EGFR -Mutant Non-Small Cell Lung Carcinoma

Cancer Research(2020)10.1158/0008-5472.can-20-0141

N/A

0.449DataRank · unranked

19 citations

Stephen Ollosi, Salvador Aparisi, Jeffrey H. Becker, Alicia Aliena‐Valero, Marta Benet +21 more

Human CD36hi monocytes induce Foxp3+ CD25+ T cells with regulatory functions from CD4 and CD8 subsets

Immunology(2021)10.1111/imm.13316

N/A

0.425DataRank · unranked

16 citations

Kathleen E. Jaeger, Yoichi Seki, Yi Wei Lim, Christina Cunha, Aleksandra Vuchkovska +8 more

T cell receptor-engineered T cells targeting a human endogenous retrovirus in kidney cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4542

N/A

0.165DataRank · unranked

2 citations

Elizabeth M. Brahmbhatt, Elena Cherkasova, Rosa Nadal, Ujjawal Savani, Stephanie Pierre +12 more

Identification of human CD4 + T cell populations with distinct antitumor activity

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2019.12.31.891317

N/A

0.104DataRank · unranked

1 citations

Hannah M. Knochelmann, Stefanie R. Bailey, Logan W. Huff, Jacob S. Bowers, Kinga Majchrzak +10 more

Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance

Cell Reports(2023)10.1016/j.celrep.2023.112314

N/A

0DataRank · unranked

10 citations

Yongxia Wu, Joel M. Chick, Andrea M. Abbott, Baishan Jiang, Jingxin Wang +13 more

Phase I results of human endogenous retrovirus type-E (HERV-E) TCR transduced T-cells in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2549

N/A

0DataRank · unranked

5 citations

Stefan Barisic, Gina Scurti, Elena Cherkasova, Long Chen, Kristen Wood +13 more

Data from Endothelin-1–Mediated Drug Resistance in EGFR-Mutant Non-Small Cell Lung Carcinoma

(2023)10.1158/0008-5472.c.6512434.v1

N/A

0DataRank · unranked

0 citations

Stephen Ollosi, Salvador Aparisi, Jeffrey H. Becker, Alicia Aliena‐Valero, Marta Benet +21 more

H 2 S-Prdx4 axis mitigates Golgi stress to bolster tumor-reactive T cell immunotherapeutic response

Science Advances(2024)10.1126/sciadv.adp1152

N/A

0DataRank · unranked

22 citations

Paramita Chakraborty, Mohamed Faisal Kassir, James W. Dressman, Satyajit Das, Stephanie Mills +19 more

Quantification of circulating TCR-engineered T cells targeting a human endogenous retrovirus post-adoptive transfer using nanoplate digital PCR

Molecular Therapy — Methods & Clinical Development(2024)10.1016/j.omtm.2024.101324

N/A

0DataRank · unranked

0 citations

Elena Cherkasova, Rosa Nadal, Xin Tian, Long Chen, Angelina Parrizzi +5 more

Melanoma reactive TCR-modified T cells generated without activation retain a less differentiated phenotype and mediate a superior in vivo response

Scientific Reports(2021)10.1038/s41598-021-92808-6

N/A

0DataRank · unranked

10 citations

Tamson V. Moore, Annika V. Dalheim, Gina Scurti, Michael I. Nishimura, Siao‐Yi Wang

HDAC inhibition prevents transgene expression downregulation and loss-of-function in T cell-receptor-transduced T cells

Molecular Therapy — Oncolytics(2021)10.1016/j.omto.2021.01.014

N/A

0DataRank · unranked

10 citations

Gina Scurti, Matthew DeJong, Siao‐Yi Wang, Annika V. Dalheim, Courtney Wagner +13 more

Melanoma-reactive TCR-modified T Cells Generated in the Absence of Activation Retain a Less-differentiated Phenotype and Have Increased Therapeutic Potential.

Research Square (Research Square)(2021)10.21203/rs.3.rs-238261/v1

N/A

0DataRank · unranked

0 citations

Tamson V. Moore, Annika V. Dalheim, Gina Scurti, Michael I. Nishimura, Siao‐Yi Wang

Genetic Modification of T Cells for the Immunotherapy of Cancer

Vaccines(2022)10.3390/vaccines10030457

N/A

0DataRank · unranked

9 citations

Natasha Lenart, Victoria Dronzek, Gina Scurti, Nasheed Hossain, Michael I. Nishimura +1 more

Siglec-5 is an inhibitory immune checkpoint molecule for human T cells

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.04.474948

N/A

0DataRank · unranked

3 citations

David G. Glanville, Gina Scurti, Paula White, Michael I. Nishimura, Andrew T. Ulijasz +2 more